| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 442,089 | 399,277 | 357,809 | 378,912 | | Cost of Revenue | 348,920 | 334,048 | 302,563 | 325,959 | | | Gross Profit | 93,169 | 65,229 | 55,246 | 52,953 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 65,918 | 62,480 | 68,128 | 58,997 | | Non Recurring | 11,067 | (309) | 1,398 | 83,862 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,184 | 3,058 | (14,280) | (89,906) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 767 | (1,216) | (2,094) | 2,477 | | Earnings Before Interest And Taxes | 16,951 | 1,842 | (16,374) | (86,229) | | Interest Expense | 17,891 | 17,190 | 11,174 | 10,405 | | Income Before Tax | (940) | (15,348) | (27,548) | (96,634) | | Income Tax Expense | (3,749) | (4,276) | (7,819) | (19,479) | | Minority Interest | (1,712) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,097 | (11,072) | (19,729) | (77,155) | | | Non-recurring Events | | Discontinued Operations | 36 | (116) | (242) | 14,121 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,133 | (11,188) | (19,971) | (63,034) | | Preferred Stock And Other Adjustments | 816 | (819) | (535) | (202) | | | Net Income Applicable To Common Shares | $1,949 | ($12,007) | ($20,506) | ($63,236) |
|
1.00% Nasdaq 
Income Statement
